2 Pharma Stocks Flashing Buy

AMRN and SRPT stocks could shine again, if past is prologue

Managing Editor
Mar 20, 2019 at 2:51 PM
facebook X logo linkedin

Pharmaceutical concerns Sarepta Therapeutics Inc (NASDAQ:SRPT) and Amarin Corporation (NASDAQ:AMRN) have recently retreated from new highs. However, both stocks are approaching key levels that could signal a bounce. Below, we'll dive into how SRPT and AMRN have been faring on the charts, and see why history indicates now may be a good time to bet on the shares' next leg higher.

SRPT Near-Term Options Attractively Priced

Sarepta stock has pulled back from its February highs above $155. The pharma name was down 2.6% at $123.22, at last check, and just came within one standard deviation of their 70-day moving average, after an lengthy stint above the trendline.

There have been seven similar retreats to this moving average over the past three years, according to data from Schaeffer's Senior Quantitative Analyst Rocky White. After these signals, SRPT shares were higher one month later by 24.98%, on average, and were positive 71% of the time. From SRPT's current perch, a similar surge would place it at $154 -- in line with its late-February highs.


Daily SRPT with 70MA

Short interest on the stock grew 3% during the most recent reporting period, and now accounts for a healthy 14.6% of SRPT's total available float. At the security's average daily trading volume, it would take shorts nearly six days to buy back their bearish bets, should the equity once again rebound off familiar support.

In terms of option premiums, SRPT's look attractively priced at the moment. Specifically, the security's Schaeffer's Volatility Index (SVI) of 51% stands in the 16th percentile of its annual range. In other words, near-term options are pricing in relatively low volatility expectations.

AMRN Shares Could Find a Floor

AMRN is down 0.8% at $18.59 in afternoon trading, eyeing its sixth close in the red over the past seven trading days. The shares have already lost more than 8% this week alone, but things may be looking up, as the pharma concern nears a historically bullish trendline.

Amarin stock just came within one standard deviation of its 50-day moving average, after an extended stretch above the trendline. This signal has occurred five times in the past three years, and has preceded an average one-month gain of 12.55% for the shares. Further, AMRN was positive 80% of the time a month after signals. From the security's current perch, a similar surge would place it at $20.92.

Fixed AMRN Daily 50Ma

As with Sarepta, Amarin's short-term options look attractively priced. Near-term options are pricing in relatively low volatility expectations, as the stock sports an SVI of 64%, just 4 percentage points from an annual low.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI